Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedAug 11, 2025
DataAggregated Company Financials
Companies9
  • 7D-1.9%
  • 3M0.9%
  • 1Y-2.8%
  • YTD2.9%

Over the last 7 days, the Pharma industry has dropped 1.9%, driven by a pullback from Roche Holding of 4.2%. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 11 Aug 2025CHF 449.9bCHF 120.8bCHF 20.9b22.2x21.5x3.7x
Wed, 09 Jul 2025CHF 452.2bCHF 117.2bCHF 18.9b24.8x23.9x3.9x
Fri, 06 Jun 2025CHF 455.1bCHF 118.9bCHF 19.2b25.7x23.7x3.8x
Sun, 04 May 2025CHF 446.5bCHF 119.2bCHF 19.3b26.2x23.2x3.7x
Tue, 01 Apr 2025CHF 460.3bCHF 121.8bCHF 19.2b27.9x23.9x3.8x
Thu, 27 Feb 2025CHF 480.5bCHF 122.0bCHF 19.0b23.4x25.2x3.9x
Sat, 25 Jan 2025CHF 450.4bCHF 119.3bCHF 21.4b18.8x21.1x3.8x
Mon, 23 Dec 2024CHF 415.3bCHF 118.6bCHF 21.2b17.5x19.6x3.5x
Wed, 20 Nov 2024CHF 425.4bCHF 117.9bCHF 21.1b18.2x20.1x3.6x
Fri, 18 Oct 2024CHF 462.9bCHF 115.9bCHF 19.5b21.9x23.8x4x
Sun, 15 Sep 2024CHF 451.0bCHF 114.8bCHF 19.3b21.6x23.4x3.9x
Tue, 13 Aug 2024CHF 457.7bCHF 115.8bCHF 19.5b21.7x23.5x4x
Thu, 11 Jul 2024CHF 438.6bCHF 116.5bCHF 19.8b34x22.2x3.8x
Sat, 08 Jun 2024CHF 426.0bCHF 116.3bCHF 19.8b44.1x21.6x3.7x
Mon, 06 May 2024CHF 389.1bCHF 113.1bCHF 19.9b39x19.6x3.4x
Wed, 03 Apr 2024CHF 401.1bCHF 112.3bCHF 19.4b36.5x20.6x3.6x
Fri, 01 Mar 2024CHF 385.5bCHF 110.6bCHF 19.7b24.1x19.6x3.5x
Sun, 28 Jan 2024CHF 413.8bCHF 120.2bCHF 18.8b27x22.1x3.4x
Tue, 26 Dec 2023CHF 394.7bCHF 119.6bCHF 18.7b25x21.1x3.3x
Thu, 23 Nov 2023CHF 390.8bCHF 121.5bCHF 18.9b24.5x20.6x3.2x
Sat, 21 Oct 2023CHF 390.9bCHF 120.9bCHF 18.6b25.7x21.1x3.2x
Mon, 18 Sep 2023CHF 413.1bCHF 112.7bCHF 18.0b47x22.9x3.7x
Wed, 16 Aug 2023CHF 409.7bCHF 111.6bCHF 17.9b48.7x22.9x3.7x
Fri, 14 Jul 2023CHF 404.8bCHF 113.2bCHF 18.6b36.8x21.7x3.6x
Sun, 11 Jun 2023CHF 428.7bCHF 115.5bCHF 18.9b37.9x22.6x3.7x
Tue, 09 May 2023CHF 438.1bCHF 114.8bCHF 18.8b41.7x23.3x3.8x
Thu, 06 Apr 2023CHF 423.5bCHF 115.2bCHF 18.9b42x22.4x3.7x
Sat, 04 Mar 2023CHF 400.5bCHF 116.9bCHF 19.1b27.2x20.9x3.4x
Mon, 30 Jan 2023CHF 445.2bCHF 118.0bCHF 34.9b23.6x12.8x3.8x
Wed, 28 Dec 2022CHF 437.2bCHF 117.4bCHF 34.7b22.6x12.6x3.7x
Fri, 25 Nov 2022CHF 442.4bCHF 118.1bCHF 35.0b23.2x12.6x3.7x
Sun, 23 Oct 2022CHF 447.0bCHF 121.7bCHF 37.5b21.2x11.9x3.7x
Tue, 20 Sep 2022CHF 446.6bCHF 119.8bCHF 36.7b21x12.2x3.7x
Thu, 18 Aug 2022CHF 449.6bCHF 119.1bCHF 36.4b21.6x12.4x3.8x
Price to Earnings Ratio

12.4x


Total Market Cap: CHF 449.6bTotal Earnings: CHF 36.4bTotal Revenue: CHF 119.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 20.5x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.5x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.21%
Healthcare-2.17%
Pharma-1.94%
Pharma-1.94%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SDZ Sandoz GroupCHF 47.292.3%
+CHF 460.9m		32.4%PS2.4x
GALD Galderma GroupCHF 130.101.5%
+CHF 451.1m		71.2%PE101.1x
NWRN Newron PharmaceuticalsCHF 7.479.4%
+CHF 12.8m		5.1%PE10x
CURN Curatis HoldingCHF 11.908.2%
+CHF 4.5m		101.7%n/a
COPN Cosmo PharmaceuticalsCHF 56.000.2%
+CHF 1.6m		-26.7%PE15.8x

Latest News

SDZ
CHF 47.29
Sandoz Group
7D
2.3%
1Y
32.4%
NOVN
CHF 94.06
Novartis
7D
-0.5%
1Y
-2.8%
ROG
CHF 246.40
Roche Holding
7D
-3.4%
1Y
-11.3%
ADXN
CHF 0.056
Addex Therapeutics
7D
-4.4%
1Y
-1.1%
COPN
CHF 56.00
Cosmo Pharmaceuticals
7D
0.2%
1Y
-26.7%
GALD
CHF 130.10
Galderma Group
7D
1.5%
1Y
71.2%
BIOV
CHF 29.00
BioVersys
7D
-12.9%
1Y
n/a
DESN
CHF 298.50
Dottikon ES Holding
7D
-5.2%
1Y
17.5%

Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors

Jun 18
Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors
CURN
CHF 11.90
Curatis Holding
7D
8.2%
1Y
101.7%
NWRN
CHF 7.47
Newron Pharmaceuticals
7D
9.4%
1Y
5.1%